Search - tctmd.com

Displaying 41 - 51 of 51

Sort: Relevancy | Date

News Daily News

La Morfología del Apéndice Auricular Izquierdo Podría Ayudar a Predecir el Riesgo de ACV en Pacientes con FA

July 31, 2012

News Daily News

Rivaroxaban May be Cost-Effective for A-fib Patients

L.A. McKeown

June 06, 2012

News Daily News

El Rivaroxaban podría ser Rentable en Pacientes con Fibrilación Auricular

L.A. McKeown

June 06, 2012

News Daily News

Watchman Works Just as Well Without Warfarin-Protected Transition

June 01, 2012

News Daily News

El Watchman Funciona Igual de Bien sin Transición Protegida con Warfarina

June 01, 2012

News Industry News

Key Clinical Data for St. Jude Medical’s Structural Heart Technologies Revealed at EuroPCR

May 16, 2012

News Industry News

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

May 11, 2012

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Conference News

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

August 28, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

L.A. McKeown

June 03, 2011

News Daily News

Dabigatran an Alternative to Warfarin for Stroke Prevention in A-Fib Patients

Kim Dalton

September 03, 2009

Advertisement

La Morfología del Apéndice Auricular Izquierdo Podría Ayudar a Predecir el Riesgo de ACV en Pacientes con FA

Rivaroxaban May be Cost-Effective for A-fib Patients

El Rivaroxaban podría ser Rentable en Pacientes con Fibrilación Auricular

Watchman Works Just as Well Without Warfarin-Protected Transition

El Watchman Funciona Igual de Bien sin Transición Protegida con Warfarina

Key Clinical Data for St. Jude Medical’s Structural Heart Technologies Revealed at EuroPCR

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Apixaban Bests Warfarin in Stroke Prevention for Atrial Fib

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

Dabigatran an Alternative to Warfarin for Stroke Prevention in A-Fib Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content